A Maryland man who took Ozempic and then became legally blind is suing the drug's manufacturer, arguing it had an obligation to warn patients that loss of sight could be a possible side effect. Todd Engel, 62, was prescribed Ozempic in 2023 to manage his Type 2 diabetes. The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy, a condition in which a loss of blood flow to the optic nerve causes sudden and irreversible vision loss.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
